<VariationArchive VariationID="1094" VariationName="NM_000642.3(AGL):c.4529dup (p.Tyr1510Ter)" VariationType="Duplication" Accession="VCV000001094" Version="18" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-06-17" DateCreated="2014-05-05" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16133" VariationID="1094">
      <GeneList>
        <Gene Symbol="AGL" FullName="amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" GeneID="178" HGNC_ID="HGNC:321" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="99849258" stop="99924023" display_start="99849258" display_stop="99924023" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="100315639" stop="100389578" display_start="100315639" display_stop="100389578" Strand="+" />
          </Location>
          <OMIM>610860</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000642.3(AGL):c.4529dup (p.Tyr1510Ter)</Name>
      <CanonicalSPDI>NC_000001.11:99921580:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="99921580" stop="99921581" display_start="99921580" display_stop="99921581" variantLength="1" positionVCF="99921580" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="100387136" stop="100387137" display_start="100387136" display_stop="100387137" variantLength="1" positionVCF="100387136" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>Y1510*</ProteinChange>
      <ProteinChange>Y1494*</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000642.3" sequenceAccession="NM_000642" sequenceVersion="3" change="c.4529dupA" MANESelect="true">
            <Expression>NM_000642.3:c.4529dupA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.100387137dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.100387137dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.99921581dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.99921581dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012865.1" sequenceAccession="NG_012865" sequenceVersion="1" change="g.76498dup">
            <Expression>NG_012865.1:g.76498dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000028.3" sequenceAccession="NM_000028" sequenceVersion="3" change="c.4529dup">
            <Expression>NM_000028.3:c.4529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000019.2" sequenceAccession="NP_000019" sequenceVersion="2" change="p.Tyr1510Terfs">
            <Expression>NP_000019.2:p.Tyr1510Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000642.3" sequenceAccession="NM_000642" sequenceVersion="3" change="c.4529dup" MANESelect="true">
            <Expression>NM_000642.3:c.4529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000633.2" sequenceAccession="NP_000633" sequenceVersion="2" change="p.Tyr1510Ter">
            <Expression>NP_000633.2:p.Tyr1510Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000643.3" sequenceAccession="NM_000643" sequenceVersion="3" change="c.4529dup">
            <Expression>NM_000643.3:c.4529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000634.2" sequenceAccession="NP_000634" sequenceVersion="2" change="p.Tyr1510Terfs">
            <Expression>NP_000634.2:p.Tyr1510Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000644.3" sequenceAccession="NM_000644" sequenceVersion="3" change="c.4529dup">
            <Expression>NM_000644.3:c.4529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000635.2" sequenceAccession="NP_000635" sequenceVersion="2" change="p.Tyr1510Terfs">
            <Expression>NP_000635.2:p.Tyr1510Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000646.3" sequenceAccession="NM_000646" sequenceVersion="3" change="c.4481dup">
            <Expression>NM_000646.3:c.4481dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000637.2" sequenceAccession="NP_000637" sequenceVersion="2" change="p.Tyr1494Terfs">
            <Expression>NP_000637.2:p.Tyr1494Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425325.1" sequenceAccession="NM_001425325" sequenceVersion="1" change="c.4529dup">
            <Expression>NM_001425325.1:c.4529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412254.1" sequenceAccession="NP_001412254" sequenceVersion="1" change="p.Tyr1510Terfs">
            <Expression>NP_001412254.1:p.Tyr1510Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425326.1" sequenceAccession="NM_001425326" sequenceVersion="1" change="c.4508dup">
            <Expression>NM_001425326.1:c.4508dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412255.1" sequenceAccession="NP_001412255" sequenceVersion="1" change="p.Tyr1503Terfs">
            <Expression>NP_001412255.1:p.Tyr1503Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425327.1" sequenceAccession="NM_001425327" sequenceVersion="1" change="c.4328dup">
            <Expression>NM_001425327.1:c.4328dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412256.1" sequenceAccession="NP_001412256" sequenceVersion="1" change="p.Tyr1443Terfs">
            <Expression>NP_001412256.1:p.Tyr1443Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425328.1" sequenceAccession="NM_001425328" sequenceVersion="1" change="c.4325dup">
            <Expression>NM_001425328.1:c.4325dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412257.1" sequenceAccession="NP_001412257" sequenceVersion="1" change="p.Tyr1442Terfs">
            <Expression>NP_001412257.1:p.Tyr1442Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425329.1" sequenceAccession="NM_001425329" sequenceVersion="1" change="c.4190dup">
            <Expression>NM_001425329.1:c.4190dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412258.1" sequenceAccession="NP_001412258" sequenceVersion="1" change="p.Tyr1397Terfs">
            <Expression>NP_001412258.1:p.Tyr1397Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425332.1" sequenceAccession="NM_001425332" sequenceVersion="1" change="c.4151dup">
            <Expression>NM_001425332.1:c.4151dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412261.1" sequenceAccession="NP_001412261" sequenceVersion="1" change="p.Tyr1384Terfs">
            <Expression>NP_001412261.1:p.Tyr1384Terfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000642.2" sequenceAccession="NM_000642" sequenceVersion="2" change="c.4529dup">
            <Expression>NM_000642.2:c.4529dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA114751" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="610860.0001" DB="OMIM" />
        <XRef Type="rs" ID="387906244" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00004" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000642.3(AGL):c.4529dup (p.Tyr1510Ter) AND Glycogen storage disease IIIa" Accession="RCV000001152" Version="4">
        <ClassifiedConditionList TraitSetID="10001">
          <ClassifiedCondition DB="MedGen" ID="C1968739">Glycogen storage disease IIIa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-01-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000642.3(AGL):c.4529dup (p.Tyr1510Ter) AND Glycogen storage disease type III" Accession="RCV000169573" Version="17">
        <ClassifiedConditionList TraitSetID="6278">
          <ClassifiedCondition DB="MedGen" ID="C0017922">Glycogen storage disease type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-24" SubmissionCount="8">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000642.3(AGL):c.4529dup (p.Tyr1510Ter) AND Inborn genetic diseases" Accession="RCV001265666" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-24" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2014-05-05" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <CitationText>Yang, B.-Z., Ding, J.-H., Bao, Y., Eason, J. F. M., Chen, Y.-T. Molecular basis of the enzymatic variability in type III glycogen storage disease (GSD-III). (Abstract) Am. J. Hum. Genet. 51 (suppl.): A28, 1992.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19299494</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20071996</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20490926</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20648714</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23062577</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23430490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8990006</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301788</ID>
          <ID Source="BookShelf">NBK26372</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10001" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9276" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IIIa</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD IIIa</ElementValue>
                <XRef ID="232400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD3a</ElementValue>
              </Symbol>
              <XRef ID="C1968739" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6278" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2236" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease type III</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+3/3123" DB="Genetic Alliance" />
                <XRef ID="66937008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Forbes disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cori disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limit dextrinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amylo-1,6-glucosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen debrancher deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD3</ElementValue>
                <XRef Type="MIM" ID="232400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9442" />
                <XRef ID="9442" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type III (GSD III) is characterized by variable liver, cardiac muscle, and skeletal muscle involvement. GSD IIIa is the most common subtype, present in about 85% of affected individuals; it manifests with liver and muscle involvement. GSD IIIb, with liver involvement only, comprises about 15% of all affected individuals. In infancy and early childhood, liver involvement presents as hepatomegaly and failure to thrive, with fasting ketotic hypoglycemia, hyperlipidemia, and elevated hepatic transaminases. In adolescence and adulthood, liver disease becomes less prominent. Most individuals develop cardiac involvement with cardiac hypertrophy and/or cardiomyopathy. Skeletal myopathy manifesting as weakness may be evident in childhood and slowly progresses, typically becoming prominent in the third to fourth decade. The overall prognosis is favorable but cannot be predicted on an individual basis. Long-term complications such as muscular and cardiac symptoms as well as liver fibrosis/cirrhosis and hepatocellular carcinoma may have a severe impact on prognosis and quality of life. To date, it is unknown if long-term complications can be alleviated and/or avoided by dietary interventions.</Attribute>
                <XRef ID="NBK26372" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301788</ID>
                <ID Source="BookShelf">NBK26372</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2010">
                <ID Source="PubMed">20631546</ID>
              </Citation>
              <XRef ID="366" DB="Orphanet" />
              <XRef ID="C0017922" DB="MedGen" />
              <XRef ID="MONDO:0009291" DB="MONDO" />
              <XRef Type="MIM" ID="232400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1363886" SubmissionDate="2018-01-25" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="NM_000642.2:c.4529dupA|MedGen:C3695007" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000697534" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23430490</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8990006</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23062577</ID>
          </Citation>
          <Comment>Variant summary: The AGL c.4529dupA (p.Tyr1510X) variant results in a premature termination codon, predicted to cause a truncated or absent AGL protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 2/121034 (1/60517), which does not exceed the estimated maximal expected allele frequency for a pathogenic AGL variant of 1/438. Multiple publications have cited the variant in affected individuals, who were homozygous and compound heterozygous. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="387906244" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.2:c.4529dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3695007" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="21302" SubmissionDate="2020-09-18" DateLastUpdated="2020-09-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610860.0001_GLYCOGEN STORAGE DISEASE, TYPE IIIa" title="AGL, 1-BP INS, 4529A_GLYCOGEN STORAGE DISEASE, TYPE IIIa" />
        <ClinVarAccession Accession="SCV000021302" DateUpdated="2020-09-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a child with an unusually severe phenotype of glycogen storage disease type IIIa (GSD3A; 232400) manifested in both liver and muscle, Shen et al. (1997) identified a homozygous 1-bp insertion (4529insA) in the 3-prime coding region of the AGL gene. The mutation created a termination codon at residue 1510 of their sequence. (They stated that amino acid residue 1510 in their study corresponded to residue 1493 of the Yang et al. (1992) sequence.) The child had recurrent hypoglycemia, seizures, severe cardiomegaly, and hepatomegaly, and died at 4 years of age.</Attribute>
              <Citation>
                <ID Source="PubMed">8990006</ID>
              </Citation>
              <Citation>
                <CitationText>Yang, B.-Z., Ding, J.-H., Bao, Y., Eason, J. F. M., Chen, Y.-T. Molecular basis of the enzymatic variability in type III glycogen storage disease (GSD-III). (Abstract) Am. J. Hum. Genet. 51 (suppl.): A28, 1992.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="232400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <Name>AGL, 1-BP INS, 4529A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 4529A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610860.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCOGEN STORAGE DISEASE, TYPE IIIa</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4055292" SubmissionDate="2022-01-28" DateLastUpdated="2022-10-01" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_000642.3:c.4529dupA|OMIM:232400" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002072438" DateUpdated="2022-10-01" DateCreated="2022-01-29" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK26372</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19299494</ID>
          </Citation>
          <Comment>Associated with more severe phenotype</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.3:c.4529dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017922" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11006061</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2851920" SubmissionDate="2020-10-09" DateLastUpdated="2023-01-07" DateCreated="2020-11-21">
        <ClinVarSubmissionID localKey="a137793" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001443833" DateUpdated="2023-01-07" DateCreated="2020-11-21" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry exome assertion method (8-5-2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/xlwdlsvu/ambry_exome_assertion_method_8-5-2015_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Caucasian/African American</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <FamilyData PedigreeID="a642232" />
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.2:c.4529dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MeSH" ID="D030342" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7120920" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="115161acdb80f1b4a95a4c6c58b36006e2a50feb498596d43f33f2df2363af4c|OMIM:232400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003816708" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.3:c.4529dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7867303" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000642.2:c.4529dup|OMIM:232400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004212970" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.2:c.4529dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2875943" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000642.3:c.4529dupA|Glycogen storage disease type III" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001460668" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.3:c.4529dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Glycogen storage disease type III</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4028751" SubmissionDate="2022-01-10" DateLastUpdated="2022-01-12" DateCreated="2022-01-12">
        <ClinVarSubmissionID localKey="NM_000642.3:c.4529dup|OMIM:232400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002055514" DateUpdated="2022-01-12" DateCreated="2022-01-12" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.3:c.4529dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10918493</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="397829" SubmissionDate="2015-03-11" DateLastUpdated="2022-12-24" DateCreated="2015-03-29">
        <ClinVarSubmissionID localKey="NM_000642.2(AGL):c.4529dupA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000221073" DateUpdated="2022-12-24" DateCreated="2015-03-29" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-01-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8990006</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20490926</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23062577</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20648714</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23430490</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.2:c.4529dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Glycogen storage disease type III</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="232400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl_2015_03_01</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5462157" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000642.3:c.4529dup|OMIM:232400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002811460" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.3:c.4529dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1461572" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2015-03-29">
        <ClinVarSubmissionID localKey="1777973|MedGen:C0017922" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000752145" DateUpdated="2024-02-20" DateCreated="2015-03-29" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8990006</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20071996</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20490926</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23430490</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr1510*) in the AGL gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 23 amino acid(s) of the AGL protein. This variant is present in population databases (rs756759628, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with glycogen storage disease type III (PMID: 8990006, 20071996, 20490926, 23430490). ClinVar contains an entry for this variant (Variation ID: 1094). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.100387136_100387137insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017922" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5462157" TraitType="Disease" MappingType="XRef" MappingValue="232400" MappingRef="OMIM">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7867303" TraitType="Disease" MappingType="XRef" MappingValue="232400" MappingRef="OMIM">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="21302" TraitType="Disease" MappingType="Name" MappingValue="GLYCOGEN STORAGE DISEASE, TYPE IIIa" MappingRef="Preferred">
        <MedGen CUI="C1968739" Name="Glycogen storage disease IIIa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4055292" TraitType="Disease" MappingType="XRef" MappingValue="C0017922" MappingRef="MedGen">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="397829" TraitType="Disease" MappingType="Name" MappingValue="Glycogen storage disease type III" MappingRef="Preferred">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2875943" TraitType="Disease" MappingType="Name" MappingValue="Glycogen storage disease type III" MappingRef="Preferred">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1363886" TraitType="Disease" MappingType="XRef" MappingValue="C3695007" MappingRef="MedGen">
        <MedGen CUI="C1968739" Name="Glycogen storage disease IIIa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2851920" TraitType="Disease" MappingType="XRef" MappingValue="D030342" MappingRef="MeSH">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4028751" TraitType="Disease" MappingType="XRef" MappingValue="232400" MappingRef="OMIM">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7120920" TraitType="Disease" MappingType="XRef" MappingValue="232400" MappingRef="OMIM">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1461572" TraitType="Disease" MappingType="XRef" MappingValue="C0017922" MappingRef="MedGen">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

